Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge.

Duperret EK, Perales-Puchalt A, Stoltz R, G H H, Mandloi N, Barlow J, Chaudhuri A, Sardesai NY, Weiner DB.

Cancer Immunol Res. 2019 Feb;7(2):174-182. doi: 10.1158/2326-6066.CIR-18-0283. Epub 2019 Jan 24.

PMID:
30679156
2.

A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers.

Manoharan M, Mandloi N, Priyadarshini S, Patil A, Gupta R, Iyer L, Gupta R, Chaudhuri A.

Front Immunol. 2018 Dec 21;9:3017. doi: 10.3389/fimmu.2018.03017. eCollection 2018.

3.

Magnetically Balanced Power and Data Telemetry for mm-scale Neural Implants.

Mandloi NK, Ha S.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:3378-3381. doi: 10.1109/EMBC.2018.8513082.

PMID:
30441112
4.

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer.

Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K.

Lung Cancer (Auckl). 2018 Jan 3;9:1-11. doi: 10.2147/LCTT.S147841. eCollection 2018.

5.

A novel splice variant in EMC1 is associated with cerebellar atrophy, visual impairment, psychomotor retardation with epilepsy.

Geetha TS, Lingappa L, Jain AR, Govindan H, Mandloi N, Murugan S, Gupta R, Vedam R.

Mol Genet Genomic Med. 2018 Mar;6(2):282-287. doi: 10.1002/mgg3.352. Epub 2017 Dec 22.

Supplemental Content

Loading ...
Support Center